The University of British Columbia
Date of Award
Type 1 Diabetes, Prevent & Delay
Term of Grant
Engineering antigen-specific regulatory T cells for use in type 1 diabetes
Funds support a work into a preclinical proof-of-principle for an engineered targeted Treg cell therapy to treat type 1 diabetes.